Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE recommends Tagrisso (osimertinib) in England for lung cancer patients

November 30, 2021
Manufacturing and Production

AstraZeneca have announced that Tagrisso (osimertinib) is now available as an adjuvant treatment option to patients in England with completely …

News

Vaccine makers pledge to develop Omicron-effective jab

November 29, 2021
Sales and Marketing

Leading vaccine producers have shared that they are already pursuing vaccine responses to the newly-discovered coronavirus variant, Omicron. BioNTech has …

News

Nottinghamshire school sets up targeted testing for Omicron

November 29, 2021
Sales and Marketing

A school in Nottingham has set up targeted testing after a case of the new COVID-19 variant, Omicron, was detected …

News
mufid-majnun-oi20ehignd4-unsplash

WHO: unclear if Omicron causes severe disease

November 29, 2021
Sales and Marketing

WHO has shared that it is still unclear whether the recently-detected coronavirus variant Omicron is more transmissible, or causes more …

News

FDA approves AI-based breast cancer screening software MammoScreen®

November 29, 2021
Sales and Marketing

The FDA has approved MammoScreen®, Therapixel’s explainable and actionable Artificial Intelligence (AI) based software assisting Radiologists in breast cancer screening. …

News

New COVID-19 variant in South Africa as massive surge in Europe infections

November 26, 2021
Medical Communications

A new variant of coronavirus found in South Africa is feared to be more transmissible than other strains, and poses …

News

Allorion gains $40 million funding to enhance and discover precision targets

November 26, 2021
Medical Communications

Allorion Therapeutics has announced that they have gained $40 million in Series A financing. The funding was led by Chinese …

News

US government expands COVID-19 booster eligibility ahead of holidays

November 25, 2021
Business Services

The Biden administration has expanded COVID-19 booster eligibility, and millions of Americans have received their booster shots at a near …

News

Groundbreaking success shown in target drug combination for aggressive brain tumours

November 25, 2021
Business Services

A combination of two targeted cancer drugs have shown unprecedented activity in patients with highly malignant brain tumours carrying a …

News

FDA approve first therapy to treat ultra-rare cancer

November 24, 2021
Research and Development

Aadi Bioscience announced that the FDA have approved the intravenous drug Fyarro (sirolimus protein-bound particles for injectable suspension) for the …

News

Ocuphire announces beginning of Phase III trial of treatment for reversal of mydriasis (RM)

November 24, 2021
Research and Development

Ocuphire Pharma, a clinical-stage ophthalmic biopharmaceutical company, announced that the first subjects have been enrolled in the MIRA-3 Phase III …

News

FDA approves Livtencity as first treatment for drug-resistant post-transplant infection

November 24, 2021
Manufacturing and Production, Research and Development

The FDA have approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients with a common type …

News

HUTCHMED and AstraZeneca begin Phase III trial of lung cancer treatment

November 24, 2021
Research and Development

HUTCHMED Limited and AstraZeneca have initiated SACHI, a China Phase III study of Savolitinib (ORPATHYS®), an oral, potent, and highly …

News

Santhera and ReveraGen announce positive results from VISION-DMD study

November 23, 2021
Manufacturing and Production

Santhera Pharmaceuticals and ReveraGen BioPharma have announced new topline results after completion of the VISION-DMD study at week 48.

News

Sterling Pharma Solutions announces £10m investment to increase manufacturing capacity

November 23, 2021
Manufacturing and Production

Contract development and manufacturing organisation Sterling Pharma Solutions has announced a £10m multi-year investment strategy for its site in Dudley, …

News

European Commission approves BYANNLI for management of schizophrenia in adults

November 23, 2021
Manufacturing and Production

Johnson & Johnson have announced the approval of the long-acting atypical antipsychotic therapy BYANNLI® by the European Commission (EC), for …

News

Breakthrough personalised T-cell therapy for children with brain tumours

November 23, 2021
Manufacturing and Production

The Centre for Cancer and Immunology Research, Children’s National Research Institute, have developed a new approach that identifies unique proteins …

News

FDA approves Pfizer and Moderna boosters for all US adults

November 22, 2021
Sales and Marketing

The FDA and CDC have cleared the Pfizer and Moderna booster jabs for adults, after reviewing new data supporting the …

News

FDA accept New Drug Application for Obseva’s linzagolix

November 22, 2021
Sales and Marketing

Obseva, a biopharmaceutical company developing and commercialising novel therapies to improve reproductive health, have announced that the NDA for linzagolix …

News

Novel mechanisms could transform standards of care in multiple cancers, MS, and Lupus

November 22, 2021
Sales and Marketing

Leading science and technology company, Merck KGaA, Darmstadt, Germany have identified five mid- to late-stage assets with first-in-class potential for …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025